GB1244738A - Antibacterial compositions - Google Patents

Antibacterial compositions

Info

Publication number
GB1244738A
GB1244738A GB44498/68A GB4449868A GB1244738A GB 1244738 A GB1244738 A GB 1244738A GB 44498/68 A GB44498/68 A GB 44498/68A GB 4449868 A GB4449868 A GB 4449868A GB 1244738 A GB1244738 A GB 1244738A
Authority
GB
United Kingdom
Prior art keywords
hetacillin
ampicillin
sept
weight
nystatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB44498/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB1244738A publication Critical patent/GB1244738A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1,244,738. Antibacterial compositions. BRISTOL-MYERS CO. 19 Sept., 1968 [20 Sept., 1967], No. 44498/68. Heading A5B. A composition for treating bacterial infection comprises 1 part by weight of nystatin to 0.15 to 50 parts by weight of ampicillin or hetacillin. A preferred dosage unit comprises 100,000- 550,000 nystatin units per unit dose with 100-600 mg. of ampicillin or hetacillin per unit dose. Preferably a composition contains a buffer to attain a pH of 2-8 when reconstituted with water (the pH is preferably 2-3 with hetacillin and 6-8 with ampicillin). Conventional sequestering agents, flavourings, suspending agents, colourings, anti-oxidants and preservatives may be added (many examples given) .
GB44498/68A 1967-09-20 1968-09-19 Antibacterial compositions Expired GB1244738A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66930167A 1967-09-20 1967-09-20

Publications (1)

Publication Number Publication Date
GB1244738A true GB1244738A (en) 1971-09-02

Family

ID=24685864

Family Applications (1)

Application Number Title Priority Date Filing Date
GB44498/68A Expired GB1244738A (en) 1967-09-20 1968-09-19 Antibacterial compositions

Country Status (6)

Country Link
BE (1) BE721209A (en)
FR (1) FR7724M (en)
GB (1) GB1244738A (en)
IE (1) IE32738B1 (en)
IL (1) IL30684A (en)
NL (1) NL6813489A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290709A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of nystatin
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
WO1998046084A1 (en) * 1997-04-11 1998-10-22 Baker's Bright, Inc. Anaerobically-packaged ready to use liquid bakery wash

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290709A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of nystatin
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
WO1998046084A1 (en) * 1997-04-11 1998-10-22 Baker's Bright, Inc. Anaerobically-packaged ready to use liquid bakery wash

Also Published As

Publication number Publication date
IL30684A (en) 1972-12-29
BE721209A (en) 1969-03-20
IE32738L (en) 1969-03-20
IL30684A0 (en) 1969-05-28
IE32738B1 (en) 1973-11-14
NL6813489A (en) 1969-03-24
FR7724M (en) 1970-03-02

Similar Documents

Publication Publication Date Title
GB1405088A (en) Slow release formulation
IE873125L (en) Benzimidazole derivatives
GB1244738A (en) Antibacterial compositions
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
IE32991L (en) Ambutyrosins
GB1244024A (en) Antibacterial compositions
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB739800A (en) Aqueous pharmaceutical solutions of reserpine for parenteral administration
GB1460325A (en) Pharmaceutical composition intended for relieving pain and producing analgesia
CA953294A (en) Preparation of 3'-4'-dideoxykanamycin b active against resistant bacteria
ES368401A1 (en) Propanolamine derivatives
GB1299037A (en) Dithiocarbamic acid esters
GB1311618A (en) 4-sulphanilyl phenyl urea complexes
GB1388041A (en) Benzimidazolyl sulphides and sulphones
GB1343619A (en) Benzoyl phenylpiperidine derivative
GB1340535A (en) Benzodiazepine derivatives
GB1168302A (en) Aluminium N-Acetylglycinate and Pharmaceutical Compositions containing the same
GB1342643A (en) Thioacetanilide derivatives
GB1255591A (en) Compositions for use as eye drops or eye lotion
GB1507623A (en) Penicillin and its preparation and use
GB1279380A (en) Improvements in or relating to hydantoins and compositions thereof
GB1317099A (en) 3-sulphamyl-4-chlorobenzoic acid derivatives
GB1269191A (en) Method of combatting mastitis in mammals
GB1276588A (en) Antibacterial composition
GB1217135A (en) Daunomycin derivatives